Startups
Overview
Location
United States, Massachusetts, Cambridge
Employees
201-500
Founded date
1991
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 5, 2012 | Merck’s bone sarcoma maintenance drug gets thumbs down from FDA | In March, the FDA’s Oncologic Drugs Advisory Committee voted 13 to 1 against recommending ridaforolimus following Merck’s new drug application submission in August last year. The FDA has previously approved mTOR inhibitor drugs for cancers ... |
| May 23, 2008 | Lies, Damned Lies, and Statistics: The Definitive Rundown on New England Biotech | Share Share on Facebook Share on Twitter LinkedIn Email Reprints It’s official: 2007 rocked for New England biotech. Whether you look at IPOs, mergers, or venture activity, the region is consistently among the nation’s leaders. And on a per... |
| Merck’s bone sarcoma maintenance drug gets thumbs down from FDA | The U.S. Food and Drug Administration has turned down, for now, Merck’s (NYSE: MRK) maintenance drug for metastatic bone sarcoma or metastatic soft tissue sarcoma just a few months after an FDA committee voted overwhelmingly against recomme... |
Reviews 0
FAQ about Ariad Pharmaceuticals Inc
When was Ariad Pharmaceuticals Inc founded?
Ariad Pharmaceuticals Inc was founded in 1991.
What has the press written about Ariad Pharmaceuticals Inc?
Parsers VC has collected 4 articles mentioning Ariad Pharmaceuticals Inc, among them “Merck’s bone sarcoma maintenance drug gets thumbs down from FDA” (Jun 5, 2012) and “Lies, Damned Lies, and Statistics: The Definitive Rundown on New England Biotech” (May 23, 2008).
Is Ariad Pharmaceuticals Inc still active?
Ariad Pharmaceuticals Inc is probably closed: its latest activity on Parsers VC dates from Jan 10, 2017.